Literature DB >> 25035432

An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression.

Young-Ju Kang1, In Cheul Jeung2, Arum Park3, Young-Jun Park3, Haiyoung Jung3, Tae-Don Kim3, Hee Gu Lee4, Inpyo Choi3, Suk Ran Yoon5.   

Abstract

STUDY QUESTION: Is the decreased natural killer (NK) cell cytolytic activity in the peritoneal fluid (PF) of endometriosis patients due to primary cytokine activity? SUMMARY ANSWER: An increased level of interleukin-6 (IL-6) in the PF of patients with endometriosis suppresses NK cell cytolytic activity by down-regulating cytolytic granule components, such as granzyme B and perforin, through the modulation of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) expression. WHAT IS ALREADY KNOWN: Endometriosis is known to be related to a defect in NK cell cytolytic activity. Additionally, the levels of inflammatory cytokines are elevated in the PF of women with endometriosis. STUDY DESIGN, SIZE, DURATION: The effects of PF on the differentiation and functional activity of NK cells were investigated in patients with or without endometriosis, and cytokines that reduce NK cell cytolytic activity in endometriosis patients were examined. The study included women who underwent laparoscopic examination for the diagnosis of endometriosis from August 2012 to July 2013 (33 women with, and 15 women without, endometriosis). PARTICIPANTS/MATERIALS, SETTING,
METHODS: Women of reproductive age (20-40 years old) who underwent laparoscopic examination for endometriosis were included. Cytokines present in the PF were identified by enzyme-linked immunosorbent assay. The cytolytic activity of NK cells in the PF was also analyzed using a calcein-acetoxy methyl ester (AM) release assay. MAIN RESULTS AND THE ROLE OF CHANCE: PF from patients with endometriosis suppressed the differentiation and cytotoxicity of NK cells compared with PF from controls (P < 0.05). Increased levels of IL-6 were also found in the PF of patients with endometriosis (P < 0.01), and IL-6 levels were negatively correlated with the cytolytic activity of NK cells (rs = -0.558, P = 0.03). Furthermore, IL-6 reduced the cytolytic activity of NK cells, concomitantly with the down-regulation of granzyme B and perforin (P < 0.05), by modulating SHP-2. Importantly, the addition of anti-IL-6 to the PF of endometriosis patients restored the activity of NK cells (P < 0.01), suggesting that IL-6 plays a crucial role in the reduction of NK cell activity in the PF of patients with endometriosis. LIMITATIONS, REASONS FOR CAUTION: PF contains various inflammatory cytokines in addition to IL-6 and so it is possible that other cytokines may affect the differentiation and activity of NK cells. WIDER IMPLICATIONS OF THE
FINDINGS: Our results imply that the suppression of IL-6 using an anti-IL-6 antibody or soluble IL-6 receptor could rescue the impairment of NK cell activity in patients with endometriosis. STUDY FUNDING/COMPETING INTERESTS: This work was supported by the KRIBB Creative Research Program (KCS3051312); the STP project (DTM0111221) of the Ministry of Knowledge & Economy and the Basic Science Research Program (RBM0271312) of the National Research Foundation of Korea (NRF) from the Ministry of Education, Science & Technology. There are no conflicts of interest.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IL-6; SHP-2; cytotoxicity; endometriosis; natural killer cell

Mesh:

Substances:

Year:  2014        PMID: 25035432     DOI: 10.1093/humrep/deu172

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  40 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

Review 2.  The Origin and Pathogenesis of Endometriosis.

Authors:  Yeh Wang; Kristen Nicholes; Ie-Ming Shih
Journal:  Annu Rev Pathol       Date:  2019-09-03       Impact factor: 23.472

3.  Immune-inflammation gene signatures in endometriosis patients.

Authors:  Soo Hyun Ahn; Kasra Khalaj; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2016-07-27       Impact factor: 7.329

4.  Analysis of CARD10 and CARD11 somatic mutations in patients with ovarian endometriosis.

Authors:  Yang Zou; Jiang-Yan Zhou; Feng Wang; Zi-Yu Zhang; Fa-Ying Liu; Yong Luo; Jun Tan; Xin Zeng; Xi-Di Wan; Ou-Ping Huang
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

5.  Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients.

Authors:  Stephany P Monsanto; Andrew K Edwards; Juhua Zhou; Prakash Nagarkatti; Mitzi Nagarkatti; Steven L Young; Bruce A Lessey; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2015-12-14       Impact factor: 7.329

Review 6.  Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).

Authors:  Xianyao Wang; Zhixu He; Xing Zhao
Journal:  Exp Ther Med       Date:  2021-02-03       Impact factor: 2.447

7.  Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis.

Authors:  Brooke C Matson; Kelsey E Quinn; Bruce A Lessey; Steven L Young; Kathleen M Caron
Journal:  Fertil Steril       Date:  2018-06-02       Impact factor: 7.329

8.  Extracellular vesicle-associated VEGF-C promotes lymphangiogenesis and immune cells infiltration in endometriosis.

Authors:  Wan-Ning Li; Kuei-Yang Hsiao; Chu-An Wang; Ning Chang; Pei-Ling Hsu; Chung-Hsien Sun; Shang-Rung Wu; Meng-Hsing Wu; Shaw-Jenq Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-01       Impact factor: 11.205

Review 9.  Pathophysiology and Immune Dysfunction in Endometriosis.

Authors:  Soo Hyun Ahn; Stephany P Monsanto; Caragh Miller; Sukhbir S Singh; Richard Thomas; Chandrakant Tayade
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

Review 10.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.